I just had the surreal conversation I thought I would have

New Post Public Reply Private Reply Replies (5) Message Board
Cassandra X Doctor580 #49064
1,001
I just had the surreal conversation I thought I would have with the CDC (Center for Disease Control).

I thought I would demonstrate to myself, yet once again, the curse of Cassandra at work in this crazy world. I have tried before to communicate to media, doctors and institutions, both government and private, a piece of information I thought they should know or pass along (amplify) to the public, society at large.

I'm just a guy trying to use his brain and, occasionally, come up with something interesting. For example, I confirmed early on, mostly from Dr. Gregory Poland, who is the head of Vaccine Research at the Mayo Clinic, that you can only catch the Covid-19 virus thru your mouth, your nose or your eyes. (Alright, anally too but I won't go there.) Wearing a mask, therefore, is an extremely important part of fighting the virus.

This was when the Surgeon General was screaming, "Don't wear masks!" I, of course, was not the only one pushing for people to wear masks but who would listen to me?

But the thing that really bugged me about this debate was that all the mask advocates were thinking of the masks as filters. They also wanted to say you needed a "good mask." I, on the other hand, wanted to weigh in and scream, "No, you do not need a great mask! People touch their faces constantly and any mask will tend to prevent you from contract transmission of the virus from your hands to your face! And any mask is better than nothing! Just look at the record of transmission in places that do wear masks!"

Only Dr. Poland responded to me out of my many outreach attempts to be heard by media, doctors and institutions. He said he agreed with me!

So tonight I decided to call up the CDC and have a chat with them about Cytodyn, Leronlimab, and, as Southern Gold and Doctor580 have called it, the most Effective drug Ever Tested against Covid-19 in a randomized, double-blinded drug trial.

I talked to a nice woman at the CDC. I asked her, "Does the CDC have an ombudsman?" She said, "How do you spell that?" .... "Nope, I did a search of the CDC data base and came up with nothing."

I said, "OK, will you do another search for me? Will you do a search for "Cytodyn"?" "Nope, nothing." "How about "Leronlimab"? I'll spell it." .... "Nope, nothing." Just as I suspected!

So then I prevailed on her to hear me out about a little company with a blockbuster anti-Covid-19 drug that the CDC doesn't seem to know about but probably should. She was intrigued and interested and took some notes and she said she would pass the information up to another level of bureaucracy and I should hear something by email in a day.

All of this went exactly as I thought it would.

This isn't conspiracy stuff, an evil invisible hand at work, Big Pharma, the Deep State, blah, blah, blah. It isn't even bureaucracy! It's just insularity! Doctors don't talk to doctors, family members won't listen to other family members who tell them to seek out "Leronlimab", institutions don't talk to other institutions, media "ain't got the time" to listen so only the loudest voices get heard. Everyone has their filters up. Nobody has ombudsman! The best way, and usually the only way, for small voice to be heard is thru connections. That's my experience.

So what do I want from the CDC? I want them to know about Cytodyn and Leronlimab, the best treatment for Covid-19 out there! I want it in there database for starters because they can't control disease if they don't even know about it! I want it to show up in the New York Times's "Treatment Tracker".

I want the CDC to say, "Where do we get some of this stuff? Why hasn't the National Institute of Health told us about this? Why hasn't Cytodyn gotten $1.6 Billion for their drug even tho they have fantastic results in their drug trials and Moderna has squat? What do you mean there is no manufacturing of this drug of any consiquence? What's the holdup?"

Connections! We have to keep trying to put a bug in the right person's ear. It's all most of us can do! Surreal!

If you do have someone who should hear about the Cytodyn and Leronlimab trials, the article at Targeted Oncology is a good one.

https://www.targetedonc.com/view/leronlimab-s...o-moderate








CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's Q3 2026: Strong Performance and Bold Moves

Updated Category News Views 0

A Deep Dive into AbbVie's Q3 2026 Numbers Bruised and battered from the ebbs and flows of the market, AbbVie (NYSE:ABBV) decided to show up in swagger mode for the third quarter of 2026. They doubled their diluted EPS year over year with a GAAP figure hitting $2.37, backed by an adjusted EPS of $3.82. You're seeing the fruits of savvy expansions and a portfolio that seems...

Continue Reading
Jereh Saturn Gensets: Powering a New Era in Energy

Updated Category News Views 59

Why Jereh Saturn Is a Game-Changer Imagine cutting down months, if not years, of setup time in a sector that's notoriously slow-moving. That's exactly what Jereh’s new Saturn Modular Gas Gensets promise. Rolled out in Yantai, China, these power units are all about efficiency and speed—right off the bat they bring immediate juice to oil and gas fields as well as...

Continue Reading
OPC Energy Refinances $825M for U.S. Power Plants

Updated Category News Views 40

Strategic Financial Move for OPC Energy Here's the scoop from the powerhouse behind some major U.S. electricity moves: OPC Energy and its subsidiary CPV nailed down a hefty $825 million financing package for the Shore and Maryland power plants. This isn’t just any old financial shuffle. Nope, they've hammered out an all-in-one refinancing deal that's setting the stage...

Continue Reading
HIZENERGY Rolls Out Power-Packed BESS for Europe

Updated Category News Views 38

Powering Europe's Energy Shift with HIZENERGY Ever felt like you're lost in the frenzy of Europe's energy transition? Well, HIZENERGY is diving headfirst into the chaos with their spiffy Commercial & Industrial Battery Energy Storage Systems (C&I BESS). Amid Europe's hunt for grid stability—with whiplash-inducing solar adoption and electricity pricing that behaves like...

Continue Reading
OPay's IPO Launches: A $19 ADS Debut on NYSE

Updated Category News Views 0

Navigating the Waters of OPay's IPO Ah, the sweet smell of an IPO in the morning. Kicks off like a shot of espresso, doesn't it? Well, OPay's got coffee beans roasting with their IPO splash today. The digital financial platform, which has been shaking up the markets in Nigeria and beyond, announced they're selling 16 million American Depositary Shares (ADSs) at $19 a pop....

Continue Reading
Abel Leads PRSA Maryland Chesapeake as New Chapter President

Updated Category News Views 66

New Leadership and Opportunities in the PR Landscape Amid all the hustle and bustle of the corporate world, something big's brewing in Baltimore's public relations sphere. Greg Abel, the go-getting mastermind behind Abel Communications, has taken the helm of the newly formed PRSA Maryland Chesapeake chapter. This isn't just about shifting chairs or fancy titles—this...

Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Updated Category News Views 0

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

Continue Reading
Epicurean Expeditions Mix Food Joy with Ocean Luxury

Updated Category News Views 50

Atlas Expands Culinary Cruise Horizons in 2027 Now here's a twist for you—cuisine meets cruise in a hefty blend of sail, chew, and swirl. Atlas Ocean Voyages is practically throwing a gourmet party on water with their 2027 Epicurean Expeditions. They're unfurling the sails alongside chef heavyweights like Crista Luedtke and wine maestro Anthony Giglio. Imagine a cruise...

Continue Reading
VIZ Media Expands Reach with MangaPlaza Partnership

Updated Category News Views 29

Manga Magic in the Digital Space Another day, another expansion, folks. VIZ Media's latest move to have its manga offerings available on MangaPlaza feels like a pretty shrewd play in the fierce arena of digital content. Who'd have thought decades ago that we'd be sitting here talking about digital comics like they’re the next Netflix? VIZ Media's expansion into...

Continue Reading
FirstEnergy Bolsters Support for Shelter Initiatives

Updated Category News Views 96

FirstEnergy Foundation's Commitment Shines Bright Alright, here's the scoop. FirstEnergy Foundation isn't just about keeping the lights on anymore. They're throwing down $620,000 to tackle one hell of a tough nut—shelter and stability. This latest infusion spreads across five states, with ten nonprofit warriors in New Jersey alone locking in $120,000 of that pot for...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $1000 Into $9,100 With This Top Stock

Updated Category News Views 40

Transform Your Investment with Old Dominion Freight Line Investors looking for strong returns often turn their attention to stocks that show consistent performance over the years. One such stock is Old Dominion Freight Line (NASDAQ: ODFL), which has impressively surpassed market performance over the last decade. With an average annual return of 24.38%, ODFL has...

Continue Reading
Focus Health Expands Medical Weight Loss Clinic in Texas

Updated Category News Views 14

Expanding Options at Irving Health & Wellness Clinic In Irving, Texas, Focus Health is shaking things up with a big fat expansion of its Irving Health & Wellness Clinic’s offerings. They're not just pumping out more of the same old same old. They're blending medical weight loss magic with aesthetic services to give folks in Dallas-Fort Worth a one-stop-shop for health...

Continue Reading
RTX Highlights Ongoing Supply Chain Challenges Amid Rising Demand

Updated Category News Views 157

RTX Corporation Discusses Supply Chain Challenges Post-Pandemic RTX Corporation (NYSE: RTX) is experiencing a decline in its share price due to ongoing issues across global supply chains, particularly in the aerospace sector stemming from the COVID-19 pandemic. Recent reports reveal significant labor shortages in high-demand jet production lines, emphasizing the urgency...

Continue Reading
Meta Platforms Inc's Challenge with Scams Affecting Growth

Updated Category News Views 212

Meta Platforms Inc and the Challenges with Scam Advertisements Meta Platforms Inc (NASDAQ: META) has recently come under scrutiny for its alleged complicity in allowing fraudulent advertisements to thrive across its popular platforms, including Facebook, Instagram, and WhatsApp. Reports indicate that the company was aware of these deceptive practices but chose not to take...

Continue Reading
Mint Incorporation Limited's Successful Market Entry with IPO

Updated Category News Views 113

Mint Incorporation Limited's Initial Public Offering Overview Mint Incorporation Limited (NASDAQ:MIMI), an emerging player in the interior design and fit-out industry, has successfully concluded its initial public offering (IPO). The company, based in Hong Kong, offered approximately 1,750,000 Class A ordinary shares at the price of $4.00 each, with trading officially...

Continue Reading